An evaluation of Neisseria gonorrhoeae antimicrobial susceptibility testing in the UK

Anu Jain, Michelle Cole, Tim Planche, Catherine A. Ison*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Abstract

The only method currently available to perform Neisseria gonorrhoeae antimicrobial susceptibility testing (Ng-AST) requires a viable organism obtained by culture. Reports of in vitro resistance to extended-spectrum cephalosporins, the treatment of choice for gonorrhoea, coupled with increasing gonorrhoea diagnoses is worrying. The aim of this study was to identify various methodologies employed by the UK microbiology laboratories to perform Ng-AST. Of the 118 laboratories that responded, 114 offered Ng-AST; the majority (82.5%, 94/114) of the laboratories used British Society for Antimicrobial Chemotherapy methodology for Ng-AST. The other main findings were infrequent use of quality control procedures and inconsistent susceptibility testing of the antibiotics used routinely for treatment.

Original languageEnglish
Pages (from-to)1013-1016
Number of pages4
JournalJournal of Clinical Pathology
Volume67
Issue number11
DOIs
Publication statusPublished - 1 Nov 2014

Fingerprint

Dive into the research topics of 'An evaluation of Neisseria gonorrhoeae antimicrobial susceptibility testing in the UK'. Together they form a unique fingerprint.

Cite this